Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations (INSPIRED)

August 19, 2026 updated by: University of California, San Francisco
This clinical trial aims to assess the impact of patient-focused and clinical-focused implementation strategies on blood pressure control. The investigators will assess the costs of these strategies and how effective they were at safely and equitably increasing home blood pressure monitoring.

Study Overview

Detailed Description

This study will focus on assessing implementation strategies to increase adoption of self-monitored blood pressure (SMBP) monitoring among low-income, culturally and linguistically diverse patients with hypertension in an urban safety net. The investigators propose a hybrid type 1 effectiveness-implementation trial of implementation strategies to increase use of SMBP monitoring with clinical support in an urban safety net system. 330 patients will be randomized to a low-intensity vs high-intensity implementation strategy for SMBP monitoring. The low-intensity strategy will replicate frequently used implementation efforts (provision of BP monitor with training on using a monitor) while the high-intensity strategy will address additional factors identified in prior work (e.g., digital literacy, social support). In six adult primary clinics, the investigators will concurrently provide a stepped-wedge clinic-level implementation strategy (clinical champions, electronic health record [EHR] tools) to increase provision of clinical support for SMBP data. To guide dissemination in other under-resourced settings, an economic evaluation will also be conducted.

Study Type

Interventional

Enrollment (Estimated)

330

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94110
        • Zuckerberg San Francisco General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years old/order
  • Any sex or gender
  • Any race or ethnicity
  • Must be receiving primary care at any of the six enrolled clinics
  • Have uncontrolled hypertension (two clinic BP readings ≥140/90 mmHg within the previous 18 months)
  • Can read and write English, Spanish, or Cantonese
  • Be able to provide consent
  • Must own a cell phone that receives SMS or text messages

Exclusion Criteria:

  • Those with conditions that might complicate remote BP monitoring:

    • Pregnancy (and 12 months postpartum)
    • Acute myocardial infarction or stroke in the last 12 months
    • End-stage renal disease on dialysis
    • Stage D heart failure
    • Active treatment for cancer (except for nonmelanoma skin cancers)
    • Pacemaker use
  • Those with dementia, in hospice care, or with serious behavioral health conditions impeding participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Low-Intensity (Usual Care)

Patient level: training on how to use a blood pressure (BP) monitor and online patient portal (ex. MyChart), receive reminders to take their BP at home, receive educational messages, and access to language-concordant educational materials.

Clinic level: training on standardized workflows and EHR tools, audit and feedback

Patients will be taught how to use a BP monitor, along with the accompanying mobile app to view their readings.
Patients will receive reminders via SMS to take their blood pressure.
One-time training with action planning, access to website with language concordant patient education, and educational text messages
Patients will receive training on how to use an online patient portal. If they are not yet enrolled in an online patient portal and would like to be, they will also be enrolled into one.
Experimental: High-Intensity

Patient level: In addition to the Low-Intensity Arm strategies, patients will be asked to attend four educational group sessions with other trial patients. Patients will also be asked to involve support persons in their hypertension management. The educational messages that patients receive will also explicitly encourage involvement of a support person.

Clinic level: training on standardized workflows and EHR tools, audit and feedback

Patients will be taught how to use a BP monitor, along with the accompanying mobile app to view their readings.
Patients will receive reminders via SMS to take their blood pressure.
One-time training with action planning, access to website with language concordant patient education, and educational text messages
Educational text messages about behavioral changes that explicitly encourage seeking support from a support person
Patients will be asked to attend in-person or online group education classes on hypertension management
Patients will receive training on how to use an online patient portal. If they are not yet enrolled in an online patient portal and would like to be, they will also be enrolled into one.
Patients will be asked to involve a caregiver or support person for all activities above, including patient portal proxy access.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in clinic systolic BP
Time Frame: Baseline, 12 months, 18 months
Baseline, 12 months, 18 months
BP Control
Time Frame: Monthly (-6 to 18 months)
Clinic patients with EHR recorded BP < 140/90
Monthly (-6 to 18 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Home Systolic BP (SBP)
Time Frame: Baseline, 12 months, 18 months
Home SBP for enrolled participants
Baseline, 12 months, 18 months
Patient Adoption
Time Frame: 12 months
Number of SMBP values per participant
12 months
Patient Activation
Time Frame: Baseline, 12 months
Patient Assessment of Chronic Illness Care (PACIC) - Minimum score: 1, Maximum score: 5. The PACIC is scored by summing participants' responses across all 20 items then dividing by 20, the number of items in the scale. Thus, scores on the PACIC range from 1 to 5 with higher scores indicating a better outcome (patient's perception of greater involvement in self-management and receipt of chronic care counseling).
Baseline, 12 months
BP Control
Time Frame: Baseline, 12 months, 18 months
Enrolled participants with controlled BP based on (a) clinic BP values; (b) home BP values
Baseline, 12 months, 18 months
Clinic adoption
Time Frame: Monthly (-6 to 18 months)
Clinic patients with EHR documented patient reported BP
Monthly (-6 to 18 months)
Costs
Time Frame: During trial; 12 months
Costs (including time, equipment, consumables) of SMBP monitoring + implementation strategies
During trial; 12 months
Reach
Time Frame: 12 months
Percent of participants who actively participate in SMBP monitoring
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elaine Khoong, MD, MS, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

May 1, 2028

Study Registration Dates

First Submitted

March 4, 2025

First Submitted That Met QC Criteria

March 7, 2025

First Posted (Actual)

March 12, 2025

Study Record Updates

Last Update Posted (Actual)

August 21, 2026

Last Update Submitted That Met QC Criteria

August 19, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe